Myanmar National Strategic Plan on Viral Hepatitis 2016-2020

Viral hepatitis is more prevalent in Asia than other regions. From the survey done among the general population in 2015 in Myanmar, the prevalence of hepatitis B was 6.5% and hepatitis C was 2.7%.

The 67th World Health Assembly in May 2014 approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis. In November 2014, Myanmar initiated the establishment of a National Hepatitis Control
Program (NHCP) following the resolution set up by the World Health Organization (WHO).

Myanmar is taking a public health approach to the treatment and care of viral hepatitis, treating not only mono-infected patients but also those co-infected with HIV, in line with the WHO’s strategic directions and the National Clinical Treatment Guidelines.